111, Inc. Sponsored ADR (NASDAQ:YI) Short Interest Down 33.5% in February

111, Inc. Sponsored ADR (NASDAQ:YIGet Free Report) saw a large decline in short interest in the month of February. As of February 13th, there was short interest totaling 25,958 shares, a decline of 33.5% from the January 29th total of 39,019 shares. Approximately 0.5% of the company’s shares are short sold. Based on an average daily trading volume, of 61,821 shares, the days-to-cover ratio is presently 0.4 days. Based on an average daily trading volume, of 61,821 shares, the days-to-cover ratio is presently 0.4 days. Approximately 0.5% of the company’s shares are short sold.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of 111 in a report on Monday, December 29th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company presently has an average rating of “Sell”.

Check Out Our Latest Stock Report on YI

111 Stock Performance

Shares of YI opened at $7.91 on Friday. The stock has a 50 day simple moving average of $5.62 and a 200 day simple moving average of $5.10. 111 has a 52-week low of $2.48 and a 52-week high of $11.35. The firm has a market capitalization of $68.34 million, a PE ratio of -9.42 and a beta of 0.67.

111 (NASDAQ:YIGet Free Report) last announced its quarterly earnings results on Wednesday, December 17th. The company reported ($1.20) earnings per share for the quarter. The business had revenue of $421.49 million for the quarter.

About 111

(Get Free Report)

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.

Featured Stories

Receive News & Ratings for 111 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 111 and related companies with MarketBeat.com's FREE daily email newsletter.